Invesco
FLGT icon

Invesco’s Fulgent Genetics FLGT Stock Holding History

Invesco’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
52,483
-4,497
-8% -$76.2K ﹤0.01% 2889
2026
Q1 		$906K Sell
56,980
-5,025
-8% -$109K ﹤0.01% 2911
2025
Q4 		$1.63M Sell
62,005
-7,194
-10% -$187K ﹤0.01% 2689
2025
Q3 		$1.56M Sell
69,199
-3,204
-4% -$66K ﹤0.01% 2730
2025
Q2 		$1.44M Sell
72,403
-4,256
-6% -$83K ﹤0.01% 2712
2025
Q1 		$1.3M Sell
76,659
-105,055
-58% -$1.79M ﹤0.01% 2722
2024
Q4 		$3.36M Buy
181,714
+22,301
+14% +$435K ﹤0.01% 2419
2024
Q3 		$3.46M Sell
159,413
-7,315
-4% -$164K ﹤0.01% 2410
2024
Q2 		$3.27M Sell
166,728
-3,811
-2% -$79.6K ﹤0.01% 2380
2024
Q1 		$3.7M Sell
170,539
-198,874
-54% -$4.94M ﹤0.01% 2401
2023
Q4 		$10.7M Buy
369,413
+56,786
+18% +$1.52M ﹤0.01% 1774
2023
Q3 		$8.36M Buy
312,627
+187,717
+150% +$6.41M ﹤0.01% 1881
2023
Q2 		$4.63M Sell
124,910
-241,033
-66% -$8.4M ﹤0.01% 2284
2023
Q1 		$11.4M Buy
365,943
+46,957
+15% +$1.51M ﹤0.01% 1692
2022
Q4 		$9.5M Sell
318,986
-90,812
-22% -$3.25M ﹤0.01% 1881
2022
Q3 		$15.6M Buy
409,798
+40,950
+11% +$2.05M 0.01% 1489
2022
Q2 		$20.1M Buy
368,848
+72,288
+24% +$3.97M 0.01% 1373
2022
Q1 		$18.5M Buy
296,560
+24,197
+9% +$1.59M ﹤0.01% 1560
2021
Q4 		$27.4M Sell
272,363
-6,723
-2% -$591K 0.01% 1353
2021
Q3 		$25.1M Sell
279,086
-20,220
-7% -$1.84M 0.01% 1433
2021
Q2 		$27.6M Sell
299,306
-263,839
-47% -$21.1M 0.01% 1401
2021
Q1 		$54.4M Sell
563,145
-111,533
-17% -$11.5M 0.01% 1029
2020
Q4 		$35.2M Buy
674,678
+281,682
+72% +$11.8M 0.01% 1161
2020
Q3 		$15.7M Buy
392,996
+371,155
+1,699% +$11.6M 0.01% 1432
2020
Q2 		$349K Sell
21,841
-13,509
-38% -$207K ﹤0.01% 3282
2020
Q1 		$380K Buy
35,350
+6,700
+23% +$93.3K ﹤0.01% 3169
2019
Q4 		$369K Buy
28,650
+15,900
+125% +$189K ﹤0.01% 3360
2019
Q3 		$132K Buy
+12,750
New +$121K ﹤0.01% 3606

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco's FLGT Position: Q2 2026 in Review

Invesco reduced its Fulgent Genetics (FLGT) stake by 7.9% in Q2 2026, selling an estimated $76.2K and leaving 52,483 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2889.

Invesco first reported a position in FLGT in Q3 2019 and has held it in 28 quarters since. The position peaked at $54.4M in Q1 2021. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Invesco held 52,483 shares of Fulgent Genetics worth $1.08M as of Q2 2026.
  • Invesco sold 4,497 Fulgent Genetics shares in Q2 2026, an estimated $76.2K.
  • Fulgent Genetics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2889 holding.
  • Invesco first reported a position in Fulgent Genetics in Q3 2019 and has held it in 28 quarters since.
  • Invesco's Fulgent Genetics position peaked at $54.4M in Q1 2021.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.